Hosted by the Society for Clinical Data Management, this regional conference brings together data management, technology, and clinical operations leaders to discuss evolving standards, AI-driven approaches, and best practices across global trials. Connect with the CRIO team to learn how modern eSource and centralized workflows can elevate data quality and trial oversight.
Please join us for one of the following sessions featuring CRIO leadership:
Date & Time: Monday, May 4 from 1:45PM to 3:15PM
Speaker: Marc Wartenberger, VP of Compliance & Security
Session: Regulatory Town Hall
Details: A highly anticipated interactive session bringing together regulatory authorities and the clinical data management community for open dialogue and exchange. Moderated discussion and audience Q&A provide attendees with the opportunity to hear directly from regulators, gain insight into the current regulatory landscape, and engage on topics shaping the future of clinical research and data management. As a special highlight for this year’s EMEA conference, the Townhall will include perspectives from the European Commission, offering a rare opportunity to explore the evolving European Health Data Space and what it may mean for the future of clinical research in Europe.
Date & Time: Tuesday, May 5 from 9:00AM to 10:15AM
Chairperson & Speaker: Jonathan Andrus, Co-CEO
Session: Reimagining Site Source: Optimizing Clinical Trial Execution for Sponsors, Sites, and Patients
Details: This session will explore the pivotal role of site source – and other site-focused digital solutions – in transforming clinical trial execution for all stakeholders: sponsors, CROs, sites, and patients. Source documents are the foundation of trial data, but when managed through paper forms or siloed systems, they create inefficiencies that ripple through the study. By adopting structured, electronic source (eSource) frameworks and integrated site technologies, stakeholders can streamline operations, reduce errors, and enable real-time collaboration.
Date & Time: Tuesday, May 5 from 1:45PM to 2:45PM
Chairperson & Speaker: Marc Wartenberger, VP of Compliance & Security
Session: From Promise to Practice: Integrating AI into Clinical Data Management for Enhanced Quality and Compliance
Details: Artificial intelligence (AI) is a hot topic in clinical research, but its practical application in clinical data management (CDM) for quality and compliance remains a challenge. This session, led by a quality and regulatory professional, will cut through the hype to focus on the tangible benefits and regulatory considerations of using AI to improve data quality and streamline workflows. We will explore real-world examples and address the critical questions that arise when introducing AI into a regulated environment.
Date & Time: Tuesday, May 5 from 3:15PM to 4:30PM
Speaker: Marc Wartenberger, VP of Compliance & Security
Session: The FDA’s new AI tool, Elsa, is ready to inspect your clinical trial. Are you?
Details: On June 2, 2025, the FDA launched its new generative AI tool, Elsa, in efforts to modernize operations through integration of AI technologies. How will your clinical trial hold up to regulatory scrutiny when the proverbial needle in a haystack is now being sought with a massive magnet? Do you have the right safety rails and demonstratable oversight to pass your inspection or is your organization in need of a modernization overhaul too?